Vicapsys Life Sciences (Vicapsys Life Sciences) Total Assets : $0.21 Mil (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is Vicapsys Life Sciences Total Assets?

Vicapsys Life Sciences's Total Assets for the quarter that ended in Sep. 2023 was $0.21 Mil.

During the past 12 months, Vicapsys Life Sciences's average Total Assets Growth Rate was -57.00% per year. During the past 3 years, the average Total Assets Growth Rate was -48.90% per year. During the past 5 years, the average Total Assets Growth Rate was -42.70% per year.

During the past 6 years, Vicapsys Life Sciences's highest 3-Year average Total Assets Growth Rate was -26.20%. The lowest was -48.90%. And the median was -43.70%.

Total Assets is connected with ROA %. Vicapsys Life Sciences's annualized ROA % for the quarter that ended in Sep. 2023 was -327.65%. Total Assets is also linked to Revenue through Asset Turnover. Vicapsys Life Sciences's Asset Turnover for the quarter that ended in Sep. 2023 was 0.00.

Vicapsys Life Sciences Total Assets Historical Data

The historical data trend for Vicapsys Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicapsys Life Sciences Total Assets Chart

Vicapsys Life Sciences Annual Data

Trend

Dec08

Dec09

Dec19

Dec20

Dec21

Dec22

Total Assets

Get a 7-Day Free Trial

2.23

0.70

0.40

0.59

0.07

Vicapsys Life Sciences Quarterly Data
	Jun10	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Assets	Get a 7-Day Free Trial															0.38	0.07	0.06	0.38	0.21

Vicapsys Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Vicapsys Life Sciences's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	-0.951	+	1.023
	=	0.07

Vicapsys Life Sciences's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	-1.334	+	1.542
	=	0.21

Vicapsys Life Sciences (OTCPK:VICP) Total Assets Explanation

Total Assets is connected with ROA %.

Vicapsys Life Sciences's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	-0.96	/	( (0.378	+	0.208)	/ 2 )
	=	-0.96	/	0.293
	=	-327.65 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Vicapsys Life Sciences's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	0	/	( (0.378	+	0.208)	/ 2 )
=	0	/	0.293
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Vicapsys Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Vicapsys Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicapsys Life Sciences (Vicapsys Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicapsys Life Sciences Inc (OTCPK:VICP) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

7778 Mcginnis Ferry Road, Suite 270, Suwanee, GA, USA, 30024

Website

https://www.vicapsys.com

Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.

Executives

Moore Bobby M Jr	10 percent owner	4125 S.B. MERRION ROAD, LAKELAND FL 33810
Robert Grammen	10 percent owner	9180 GALLENA COURT, NAPLES FL 34109
Michael Yurkowski	director	1505 ELM STREET, #1504, DALLAS TX 75201
William P. Esping	10 percent owner	2828 ROUTH STREET, SUITE 500, DALLAS TX 75201
Rodger Rees	director	C/O BONDS.COM GROUP, INC., 1515 SOUTH FEDERAL HIGHWAY, SUITE 212, BOCA RATON FL 33432
Mark Feldmesser	director	641 UNIVERSITY BLVE, JUPITER FL 33458
Federico Pier	director	1004 PLUM DRIVE, IRVING TX 75063
Ryan Seddon	director, 10 percent owner	8120 BELVEDERE ROAD, SUITE 4, WEST PALM BEACH FL 33411

Vicapsys Life Sciences (Vicapsys Life Sciences) Headlines

From GuruFocus

ViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive Officer

By ACCESSWIRE ACCESSWIRE • 04-13-2022